Polarean Imaging PLC Ordinary Shares (POLX)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

0.08p

Buy

0.09p

arrow-up0.0025p (+3.13%)

Prices updated at 18 Dec 2025, 14:12 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

Polarean Imaging PLC and its subsidiary are engaged in developing next generation medical imaging technology. It develops equipment that enables existing MRI systems to achieve an improved level of pulmonary functional imaging.

Income statement

20232024
890,9333m
335,4831m
-13m-9m
-1,409.33-283.15
-12m-9m
-11m-8m
Sales, General and administrative7m5m
Interest expenses15,99016,178
Provision for income taxes--
Operating expenses13m10m
Income before taxes-12m-9m
Net income available to common shareholders-12m-9m
-0.046915-0.011
Net interest income-15,231-16,118
Advertising and promotion--
Net investment income, net370,591225,478
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.046915-0.011
Free cash flow per share-0.041-0.0176
Book value/share0.03850.0104
Debt equity ratio0.0090190.030822

Balance sheet

20232024
Current assets9m14m
Current liabilities2m3m
Total capital8m12m
Total debt216,691503,786
Total equity8m12m
Total non current liabilities--
Loans--
Total assets11m16m
Total liabilities--
Cash and cash equivalents6m12m
Common stock253m1,207m

Cash flow

20232024
Cash at beginning of period16m6m
Cash dividends paid--
-11m-6m
Investments (gains) losses219,98477,204
6m12m
Net income--
-10m-6m
-78,915-197,634
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.